StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 1/30
$17.49−0.50 (-2.78%)

Close on Nov 13, 2026Market cap $1.27BP/E –Yield –

Omeros operating margin

Operating margin is operating income as a percentage of revenue.

Omeros's operating margin for the twelve months ending Mar 31, 2021 was -185.3%. For fiscal 2020 it was -212.6%, against -130.6% the year before. The highest annual figure on record is -67.7% in fiscal 2017.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-212.6%−82.0
FY2019Dec 31, 2019-130.6%+245.1
FY2018Dec 31, 2018-375.7%−308.0
FY2017Dec 31, 2017-67.7%+62.7
FY2016Dec 31, 2016-130.4%+396.9
FY2015Dec 31, 2015-527.3%+12461.2
FY2014Dec 31, 2014-12988.5%−9831.2
FY2013Dec 31, 2013-3157.3%−2544.7
FY2012Dec 31, 2012-612.5%−6.6
FY2011Dec 31, 2011-605.9%+824.3
FY2010Dec 31, 2010-1430.2%+7.3
FY2009Dec 31, 2009-1437.5%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 20260.3%+97.6
Q1 FY2026Mar 31, 2026-176.1%+28.5
Q1 FY2021Mar 31, 2021-215.0%−114.4
Q4 FY2020Dec 31, 2020-318.1%−247.1
Q3 FY2020Sep 30, 2020-97.4%−60.2
Q2 FY2020Jun 30, 2020-204.6%−169.7
Q1 FY2020Mar 31, 2020-100.6%−12.3
Q4 FY2019Dec 31, 2019-70.9%+13.0
Q3 FY2019Sep 30, 2019-37.2%+732.0
Q2 FY2019Jun 30, 2019-34.9%+1815.1
Q1 FY2019Mar 31, 2019-88.3%+1655.3
Q4 FY2018Dec 31, 2018-83.9%+18.7
Q3 FY2018Sep 30, 2018-769.1%−745.5
Q2 FY2018Jun 30, 2018-1850.0%−1780.4
Q1 FY2018Mar 31, 2018-1743.6%−1639.8
Q4 FY2017Dec 31, 2017-102.6%−10.7
Q3 FY2017Sep 30, 2017-23.6%+83.0
Q2 FY2017Jun 30, 2017-69.6%+39.6
Q1 FY2017Mar 31, 2017-103.8%–
Q4 FY2016Dec 31, 2016-91.9%–
Q3 FY2016Sep 30, 2016-106.6%–
Q2 FY2016Jun 30, 2016-109.2%–

More Omeros figures

See a number that looks wrong?